CEimpact Podcast

What happens when pharmacy law and patient care don’t align? As a pharmacist during the COVID-19 pandemic, you are dealing with balancing legal liability and vaccine administration daily through ever…

Repost Episode: Cognitive biases are pervasive and particularly troublesome in medicine. And guess what...we are all susceptible to cognitive biases! However, it is possible to learn to identify our …

Pseudogout, or Calcium Pyrophosphate Deposition Disease (CPDD), is more common than you think – plus the treatment is even murkier. In this episode, we discuss its presentation, diagnosis, and treatm…

For over 50 years, the standard has been that Staph aureus bacteremia and endovascular infections must be treated with a bactericidal antibiotic, like beta lactams or vancomycin. A new study suggests…

Can a ‘report card' tame excessive prescriptions of antibiotics in outpatient settings? In this episode Dr. Wall with guest Josh Yost, MD, FACP will evaluate a paper that looked at using 'report card…

Anti-mask and anti-vaccine fervor are causing an overload of the healthcare system and leading to increased mortality and morbidity. Three publications recently released, including a randomized contr…

The recent ESCAPED study examines the treatment of Vaso-occlusive Crisis (VOC) in persons with Sickle Cell Disease (SCD). Many patients have difficulty receiving treatment due to a myriad of factors,…

Recent studies have suggested that a short course of antibiotics, compared to longer durations, are just as efficacious for many common infections. The appropriate duration of urinary tract infection…

The United States Preventative Services Task Force (USPSTF) announced new recommendations for diabetes screening. Approximately 34.5% of the US population has pre-diabetes – frequently attributed to …

Proton Pump Inhibitors (PPIs), like all drugs, cause adverse drug events. Given the sheer number of patients prescribed, or using over-the-counter, PPIs, many practitioners may question continued use…

The Delta variant has made it clear the COVID pandemic is far from over. Recent studies have suggested that immunocompromised patients may have a reduced or no antibody response to the currently avai…

A landmark paper published in 2002 set the standard for Targeted Temperature Management (TTM)  by having hospitals use TTM protocols to "cool" patients for a period of time after cardiac arrest to im…

Do psychedelics treat mental illness? In this GameChanger episode host, Geoff Wall and guest, Sarah Grady, a psychiatric pharmacist, discuss a recent NEJM article comparing psilocybin (magic mushroom…

The delta variant of COVID-19 has put the US in the precarious position of a fourth wave of the disease -- how efficacious are our vaccines against this variant? Also, are any new treatments for earl…

The first new treatment for Alzheimer's, aducanumab, was approved by the Food and Drug Administration on June 7, 2021. This approval did not come without controversy. Learn what the available data sh…

A new study evaluates the cost-effectiveness of dapagliflozin in heart failure. Geoff and Jake continue the conversation from "Home Sweet Home (It's Where the Heart Is)" [Previous Episode] about the …

New asthma guidelines came out in 2020, yet the answer to triple or dual inhaler therapy wasn't explicitly answered. In this episode host, Geoff Wall and guest, Jake Galdo discuss the role of triple …

The recently published ADAPTABLE study seeks to answer, definitively, a long held question: What is the correct dose of aspirin to improve outcomes in secondary prevention of cardiovascular disease? …

Vaccines are the mainstay of care in the COVID-19 pandemic. However, patients may still become infected and need treatment options. Two studies have evaluated the role of inhaled budesonide for the e…

Diuretics, thiazide, and loop are critical medications for a number of disease states. Yet, they are often used inappropriately, either on the wrong dose or schedule or prescribed in patients who may…